Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Philippines receives Chinese vaccine, but Duterte prefers another brand

Published 02/28/2021, 05:49 AM
Updated 02/28/2021, 08:46 AM
© Reuters. First shipment of COVID-19 vaccine arrives in Philippines

By Enrico Dela Cruz

MANILA (Reuters) - The Philippines received its initial batch of COVID-19 vaccine doses on Sunday in a shipment donated by China, a day before its inoculation drive is due to begin, but President Rodrigo Duterte will not be among the first to be vaccinated.

Duterte attended a ceremony to mark the arrival of the initial 600,000 doses of Sinovac Biotech's CoronaVac, which were delivered by a Chinese military aircraft ahead of a further 25 million CoronaVac doses due to be delivered in batches this year.

But Duterte, who turns 77 next month, told a news briefing that, though he wants to be vaccinated, his doctor wants a different Chinese brand of vaccine for him.

His comment emphasises the lack of support the Phillipines' faces as it launches its inoculation drive. One opinion poll showed that less than a third of Filipinos are willing to be vaccinated because of perceptions over potential side-effects.

The country's vaccination campaign is targeting healthcare workers, police and military personnel initially. It has also negotiated supply deals with other manufacturers, aiming to inoculate 70 million people, or two thirds of the population.

The Philippines is the last Southeast Asian country to receive initial vaccine supplies, fuelling concerns over recovery prospects for a consumption-driven economy that suffered its worst slump on record last year, hit by lengthy coronavirus lockdowns.

"What you see now are donated vaccines. The problem is everyone is rushing to secure supplies," Duterte said at the media briefing.

"Until there is residual supply, we'll just have to wait."

© Reuters. First shipment of COVID-19 vaccine arrives in Philippines

Duterte vowed to ease restrictions further to support economic recovery but only when more vaccines become available.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.